All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
ROMISET 125MCG INJECTION 6ML_1
ROMISET 125MCG INJECTION 6ML_2
ROMISET 125MCG INJECTION 6ML_1
15% Off

Romiset 125mcg Injection 6ml

Prescription Required

cold-chain

Salt Composition : Romiplostim

Manufacturer : ALKEM LABORATORIES LTD

Origin of Medicine : India

MRP: 2520
Price :2140
You Save :380 (15%)

1 Vial(s) Of 6ml

Prepaid Only. Non-Returnable


Introduction to Romiset 125mcg Injection 6ml

Romiset 125mcg injection 6ml belongs to the platelet-stimulating agent category, containing the active ingredient Romiplostim. It treats immune primary thrombocytopenia (ITP). ITP occurs when the body's immune system mistakenly attacks and destroys its own platelets, leading to low platelet counts. This drug is mostly used in adults and children aged 18 years and over with immune primary thrombocytopenia when other treatments have not been effective. It is prescribed when immunoglobulins, corticosteroids, or splenectomy (surgical spleen removal) have not successfully increased platelet counts.

This drug is contraindicated in individuals with known hypersensitivity or allergic reactions to other medicines that are produced by DNA technology using the micro-organism Escherichia coli (E. coli). Before receiving this injection, it is important to inform your physician about certain conditions such as liver problems, cancer, recent surgery, smoking habits, and if you are taking birth control pills. These factors may impact the safety and effectiveness of the medication, and your physician needs to be aware of them to determine if Romiset 125mcg injection 6ml is suitable for you or if any adjustments need to be made to your treatment plan.

When you are on treatment with this drug, your physician will monitor your blood tests regularly to assess for any abnormalities that may indicate bone marrow changes. If abnormalities are detected, your doctor will evaluate their significance and determine the appropriate course of action because this drug has been associated with major changes in the bone marrow. Depending on the findings, your doctor may decide to continue or discontinue the treatment. Romiset 125mcg injection 6ml is not recommended for pregnant patients unless specifically indicated by your doctor. Inform your physician if you are pregnant, suspecting, or planning for the pregnancy before initiating the treatment. It is not known whether this drug is present in human milk. Therefore breastfeeding should be avoided.


Uses of Romiset 125mcg Injection 6ml

  • Treatment of immune thrombocytopenia (ITP)

Therapeutic Effects of Romiset 125mcg Injection 6ml

Romiset 125mcg injection 6ml works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, which promotes the development and maturation of platelets. This helps to increase the platelet count in individuals with ITP.


Interaction of Romiset 125mcg Injection 6ml with other drugs

Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Romiset 125mcg injection 6ml and reduce effectiveness by causing undesirable side effects.


More Information about Romiset 125mcg Injection 6ml

  • Store Romiset 125mcg injection 6ml in a refrigerator (2°C - 8°C).
  • Do not freeze.

How to consume Romiset 125mcg Injection 6ml

Romiset 125mcg injection 6ml will be administered to you by a healthcare professional in a hospital setting. It is usually administered as a subcutaneous injection (under the skin). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.


Safety Advices for Romiset 125mcg Injection 6ml

Image Not Available  

Pregnancy

  

Romiset 125mcg injection 6ml is not recommended for pregnant patients unless specifically indicated by your doctor. Inform your physician if you are pregnant, suspecting, or planning for the pregnancy before initiating the treatment.

Image Not Available  

Breast Feeding

  

It is not known whether Romiset 125mcg injection 6ml is present in human milk. Therefore, this drug is not recommended for use while breastfeeding.

Image Not Available  

Lungs

  

It is unknown whether Romiset 125mcg injection 6ml is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.

Image Not Available  

Liver

  

It is unknown whether Romiset 125mcg injection 6ml is safe for patients with liver problems. Inform your physician if you have liver disease before starting the treatment. 

Image Not Available  

Alcohol

  

It is unknown whether consuming alcohol interacts with Romiset 125mcg injection 6ml. Please consult your doctor for more advice.

Image Not Available  

Driving

  

Some side effects of Romiset 125mcg injection 6ml may impair your ability to drive or operate machinery safely. It is advisable to discuss this with your doctor before engaging in such activities.


Side Effects of Romiset 125mcg Injection 6ml

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious

  • Loss of response
  • Progression of Myelodysplastic syndromes
  • Thromboembolic complications
  • Leukemia
  • Higher risk of blood clots

Common 

  • Headache, dizziness
  • Allergic reaction
  • Upper respiratory tract infection
  • Joint pain, muscle pain
  • Indigestion
  • Sleeping trouble
  • Tingling or numbness of feet or hands
  • Abdominal pain, diarrhea, indigestion
  • Fever, cough

Word of Advice

Since Romiset 125mcg injection 6ml affects platelet production, it's essential to take precautions to avoid injuries and bleeding. Be cautious when engaging in activities that may increase your risk of injury, and report any unusual bleeding or bruising to your physician.


FAQs

Q 1. What precautions should be taken before using Romiset 125mcg injection 6ml?

Before taking Romiset 125mcg injection 6ml, it is important to inform your physician about any liver problems, history of cancer, recent surgeries, smoking habits, and the use of birth control pills. These factors may affect the safety and effectiveness of the medication, and your physician needs to be aware of them.

Q 2. What are the common side effects of Romiset 125mcg injection 6ml?

The most common side effects of Romiset 125mcg injection 6ml include headache and respiratory tract infections. However, side effects can vary from person to person. If you experience any concerning side effects or have any concerns, it is advisable to consult your physician.

Q 3. How is Romiset 125mcg injection 6ml administered?

Romiset 125mcg injection 6ml is administered through subcutaneous injections (under the skin). Your physician will provide the specific dosing and administration instructions.

Q 4. How does Romiset 125mcg injection 6ml work?

Romiset 125mcg injection 6ml works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, promoting platelet development and maturation. This helps to increase the platelet count in individuals with ITP.

Q 5. Can Romiset 125mcg injection 6ml be used in children?

Romiset 125mcg injection 6ml is approved for use in adults and children aged 18 years and over with immune primary thrombocytopenia (ITP) when other treatments are ineffective. The pediatrician will determine the dosing and administration.


Fact Box of Romiset 125mcg Injection 6ml

Molecule name: Romiplostim

Therapeutic class: Platelet-stimulating agents

Pharmacological class:  Thrombopoietin receptor agonists

Indications: Treatment of immune thrombocytopenia (ITP)


References

  1. Amgen Limited, Electronic medicines compendium (EMC), [ Revised on Oct 2021] [ Accessed on 14th July 2023],https://www.medicines.org.uk/emc/files/pil.567.pdf
  2. Amgen Inc, US Food and Drug Administration, [ Revised on Dec 2018] [Accessed on 14th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125268s163lbl.pdf
  3. Douglas B.cines et al.; Safety and efficacy of romiplostim in splenectomized patients with primary immune thrombocytopenia; Haematologica; Published on August 2017; Accessed on 14th July 2023; https://www.haematologica.org/article/view/8154

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.